People: Aclaris Therapeutics Inc (ACRS.OQ)
26 Jun 2019
Mr. Stuart D. Shanler M.D. is Chief Scientific Officer since July 2012. Since January 2014, Dr. Shanler has served part-time as a medical and clinical development consultant at Ralexar Therapeutics, Inc., a specialty dermatology company. Between 2011 and 2012, Dr. Shanler served as a consultant to a number of pharmaceutical companies. Dr. Shanler co-invented RHOFADE, a topical drug for the treatment of persistent facial erythema, for, and co-founded and served as Chief Scientific Officer of, Vicept Therapeutics, Inc. from 2009 until its acquisition by Allergan, Inc. in July 2011. Previously, Dr. Shanler was a dermatologic surgeon in private practice. Dr. Shanler is a board-certified dermatologist and received his M.D. degree from Albany Medical College of Union University and received B.S. degrees in Biology and the Biological Basis of Behavior from the University of Pennsylvania.
|Total Annual Compensation, USD||400,000|
|Restricted Stock Award, USD||342,395|
|Long-Term Incentive Plans, USD||--|
|All Other, USD||1,066,040|
|Fiscal Year Total, USD||1,808,440|